Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.4K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.4K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.2K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.9K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.9K
Neuroplasticity01:01

Neuroplasticity

1.2K
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
1.2K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

584
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
584
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

721
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
721

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shaping the future: Evolution and growth of PGY2 emergency medicine residency programs.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

Sugammadex Should Not be Used to Routinely Reverse Rocuronium for Patients in the Emergency Department.

Annals of emergency medicine·2024
Same author

Methadone Initiation in the Emergency Department for Opioid Use Disorder.

The western journal of emergency medicine·2024
Same author

Pathophysiology and treatment of adults with arrhythmias in the emergency department, part 2: Ventricular and bradyarrhythmias.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2023
Same author

Pathophysiology and treatment of adults with arrhythmias in the emergency department, part 1: Atrial arrhythmias.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2023
Same author

Staying InformED: Top emergency Medicine pharmacotherapy articles of 2020.

The American journal of emergency medicine·2021

Related Experiment Video

Updated: Nov 29, 2025

A Pressure Injection System for Investigating the Neuropharmacology of Information Processing in Awake Behaving Macaque Monkey Cortex
09:46

A Pressure Injection System for Investigating the Neuropharmacology of Information Processing in Awake Behaving Macaque Monkey Cortex

Published on: March 14, 2016

8.6K

Emergency Neuropharmacology.

Kyle M DeWitt1, Blake A Porter2

  • 1Emergency Medicine, Department of Pharmacy, The University of Vermont Medical Center, 111 Colchester Avenue, Mailstop 272 BA1, Burlington, VT 05401, USA.

Emergency Medicine Clinics of North America
|November 21, 2020
PubMed
Summary
This summary is machine-generated.

This review covers pharmacotherapy for acute neurologic emergencies in the emergency department, including traumatic brain injury and status epilepticus, to reduce patient morbidity and mortality.

Keywords:
CNS infectionMedicationPharmacokineticsPharmacotherapyStatus epilepticusTraumatic brain injuryTreatment

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.1K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.9K

Related Experiment Videos

Last Updated: Nov 29, 2025

A Pressure Injection System for Investigating the Neuropharmacology of Information Processing in Awake Behaving Macaque Monkey Cortex
09:46

A Pressure Injection System for Investigating the Neuropharmacology of Information Processing in Awake Behaving Macaque Monkey Cortex

Published on: March 14, 2016

8.6K
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.1K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.9K

Area of Science:

  • Emergency Medicine
  • Neurology
  • Pharmacology

Background:

  • Acute neurologic disorders require prompt management in the emergency department.
  • Pharmacotherapy is crucial in reducing morbidity and mortality from neurologic injury.
  • Individualized treatment approaches are essential for patient-specific factors.

Purpose of the Study:

  • To review the pharmacotherapy for common neurologic emergencies.
  • To provide clinicians with evidence-based medication strategies.
  • To highlight the importance of tailored treatment in emergency neurologic care.

Main Methods:

  • Literature review of pharmacologic interventions for neurologic emergencies.
  • Focus on conditions such as traumatic brain injury, CNS infections, status epilepticus, hypertensive emergencies, spinal cord injury, and neurogenic shock.
  • Synthesis of current treatment guidelines and evidence.

Main Results:

  • Pharmacologic agents play a vital role in managing acute neurologic conditions.
  • Specific medications are indicated for conditions like status epilepticus and hypertensive emergencies.
  • Treatment strategies aim to mitigate secondary brain injury and improve outcomes.

Conclusions:

  • Effective pharmacotherapy is a cornerstone of managing neurologic emergencies.
  • An individualized approach considering patient factors is critical for optimal outcomes.
  • This review provides a guide for clinicians on medication use in neurologic emergencies.